Crossmark Global Holdings Inc. Invests $228,000 in Addus HomeCare Co. (NASDAQ:ADUS)

Crossmark Global Holdings Inc. purchased a new position in Addus HomeCare Co. (NASDAQ:ADUS) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,712 shares of the company’s stock, valued at approximately $228,000.

Several other institutional investors also recently added to or reduced their stakes in ADUS. UMB Bank n.a. increased its position in shares of Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after acquiring an additional 88 shares during the period. Quest Partners LLC bought a new stake in Addus HomeCare during the 2nd quarter valued at $31,000. Farther Finance Advisors LLC lifted its holdings in shares of Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after buying an additional 366 shares during the period. Innealta Capital LLC purchased a new position in shares of Addus HomeCare during the second quarter valued at $44,000. Finally, EntryPoint Capital LLC bought a new stake in shares of Addus HomeCare in the first quarter valued at about $44,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on ADUS shares. KeyCorp began coverage on shares of Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target for the company. Oppenheimer increased their target price on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a research report on Thursday, November 14th. Stephens raised their price objective on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. Finally, Macquarie reiterated an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Addus HomeCare has an average rating of “Moderate Buy” and a consensus price target of $131.63.

Addus HomeCare Stock Performance

Shares of ADUS stock opened at $118.27 on Tuesday. The firm has a market capitalization of $2.14 billion, a price-to-earnings ratio of 27.06, a PEG ratio of 2.09 and a beta of 1.04. The stock’s 50-day simple moving average is $128.82 and its 200-day simple moving average is $122.73. Addus HomeCare Co. has a fifty-two week low of $85.43 and a fifty-two week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. During the same quarter in the prior year, the business posted $1.03 EPS. Addus HomeCare’s revenue for the quarter was up 7.1% compared to the same quarter last year. As a group, equities analysts forecast that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Insider Activity at Addus HomeCare

In other news, Director Esteban Lopez sold 500 shares of the stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the sale, the director now owns 3,366 shares in the company, valued at $429,165. This represents a 12.93 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. This trade represents a 75.23 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock valued at $3,050,082 in the last ninety days. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.